Related Experiment Video

Updated: Jun 13, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

What we know and do not know about sex and cardiac disease

John P Konhilas1

  • 1Department of Physiology, Molecular Cardiovascular Research Program, Sarver Heart Center, University of Arizona, 1656 E Mabel, Medical Research Building, Room 320, Tucson, AZ 85724, USA. konhilas@arizona.edu

Journal of Biomedicine & Biotechnology
|May 7, 2010
PubMed

Insights

Sex differences in congestive heart failure (CHF) are significant. Understanding these disparities in cardiovascular disease (CVD) requires examining sex-specific cellular mechanisms for better outcomes.

Area of Science:

  • Cardiology
  • Sex Differences in Medicine
  • Molecular Biology

Background:

  • Cardiovascular disease (CVD) is the leading cause of death globally.
  • Congestive heart failure (CHF) is a common outcome for CVD patients.
  • Sex differences in CHF etiology, development, and outcomes are increasingly recognized.

Purpose of the Study:

  • To highlight key aspects of sex differences in CVD and CHF.
  • To emphasize unanswered questions regarding these sex dimorphisms.
  • To advocate for sex-specific cellular mechanism analysis in CHF research.

Main Methods:

  • Review of existing literature on sex differences in cardiac disease.
  • Analysis of inconsistencies in current research findings.
  • Focus on the complex interplay of genetic and non-genetic factors in CHF development.

Main Results:

  • Women with CHF are often older and present with preserved systolic function compared to men.
  • Significant inconsistencies exist in the literature regarding underlying mechanisms of sex dimorphisms.
  • The precise molecular mechanisms driving sex differences in CHF remain unclear.

Conclusions:

  • Understanding sex dimorphisms in CHF is critical for effective treatment.
  • Cellular mechanisms must be analyzed within the context of each sex.
  • Further research is needed to resolve inconsistencies and clarify molecular pathways.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...